Front & Back Matter.
- Published in:
- Chemotherapy (0009-3157), 2020, v. 65, n. 5-6, p. 1, doi. 10.1159/000515486
- Publication type:
- Article
Works matching IS 00093157 AND DT 2020 AND VI 65 AND IP 5-6
Results: 12
1
2
Acknowledgement to Reviewers.
- Published in:
- Chemotherapy (0009-3157), 2020, v. 65, n. 5-6, p. 171, doi. 10.1159/000515093
- Publication type:
- Article
3
Contents Vol. 65, 2020.
- Published in:
- Chemotherapy (0009-3157), 2020, v. 65, n. 5-6, p. I, doi. 10.1159/000515092
- Publication type:
- Article
4
Managing the Journey of Patients under Chemotherapy in a Pandemic Era: A Nursing Perspective.
- Published in:
- Chemotherapy (0009-3157), 2020, v. 65, n. 5-6, p. 115, doi. 10.1159/000513140
- By:
- Publication type:
- Article
5
Optimal Contact Concentration of Paclitaxel in the Collagen Gel Droplet-Embedded Culture Drug Sensitivity Test for Human Oral Squamous Cell Carcinoma and Evaluation of Combination with Cetuximab.
- Published in:
- Chemotherapy (0009-3157), 2020, v. 65, n. 5-6, p. 147, doi. 10.1159/000512542
- By:
- Publication type:
- Article
6
Rescue Therapy of Refractory Diffuse Large B-Cell Lymphomas BCL2 with Venetoclax: Case Report.
- Published in:
- Chemotherapy (0009-3157), 2020, v. 65, n. 5-6, p. 161, doi. 10.1159/000512541
- By:
- Publication type:
- Article
7
Rapid Response of Breast Cancer Cutaneous Metastasis to Single-Agent Palbociclib: A Case Report.
- Published in:
- Chemotherapy (0009-3157), 2020, v. 65, n. 5-6, p. 158, doi. 10.1159/000512499
- By:
- Publication type:
- Article
8
Minimal Residual Disease Eradication by Azacitidine Maintenance in a Patient with Core-Binding Factor Acute Myeloid Leukemia.
- Published in:
- Chemotherapy (0009-3157), 2020, v. 65, n. 5-6, p. 166, doi. 10.1159/000512314
- By:
- Publication type:
- Article
9
"Door to Treatment" Outcomes of Cancer Patients during the COVID-19 Pandemic.
- Published in:
- Chemotherapy (0009-3157), 2020, v. 65, n. 5-6, p. 141, doi. 10.1159/000511884
- By:
- Publication type:
- Article
10
Oncologic Outcomes of Salvage Chemotherapy in Patients with Recurrent or Metastatic Lesions after Radical Nephroureterectomy: A Multi-Institutional Retrospective Study.
- Published in:
- Chemotherapy (0009-3157), 2020, v. 65, n. 5-6, p. 134, doi. 10.1159/000511667
- By:
- Publication type:
- Article
11
Protein Disulfide Isomerase 4 Drives Docetaxel Resistance in Prostate Cancer.
- Published in:
- Chemotherapy (0009-3157), 2020, v. 65, n. 5-6, p. 125, doi. 10.1159/000511505
- By:
- Publication type:
- Article
12
Appropriate Number of Docetaxel Cycles in Castration-Resistant Prostate Cancer Patients Considering Peripheral Neuropathy and Oncological Control.
- Published in:
- Chemotherapy (0009-3157), 2020, v. 65, n. 5-6, p. 119, doi. 10.1159/000510900
- By:
- Publication type:
- Article